Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalent, Inc. (CTLT)  
$55.47 0.51 (0.93%) as of 4:30 Wed 6/5


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 207,851,000
Market Cap: 11.53(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $32.18 - $59.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,000 1,000
Total Buy Value $0 $0 $49,980 $49,980
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 1,788 1,788 12,464 117,983
Total Sell Value $97,772 $97,772 $588,604 $11,227,385
Total People Sold 2 2 12 18
Total Sell Transactions 2 2 26 70
End Date 2024-03-09 2023-12-07 2023-06-08 2022-06-08

   
Records found: 821
  Page 17 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schmidt Kay A SVP, Technical Operations   •       –      –    2020-07-24 4 D $81.64 $41,147 D/D (504) 11,517     -
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2020-07-24 4 D $81.64 $52,739 D/D (646) 12,719     -
   Chiminski John R Chair & CEO   •       •      –    2020-07-24 4 D $81.64 $542,253 D/D (6,642) 207,965     -
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2020-06-29 4 AS $71.90 $203,318 D/D (2,824) 13,365 42%     
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2020-06-25 4 AS $73.00 $607,725 D/D (8,325) 44,520 40%     
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2020-06-25 4 D $73.00 $1,016,890 D/D (13,930) 52,845     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2020-06-25 4 OE $24.44 $622,541 D/D 22,255 59,736     -
   Carroll J Martin Director   –       •      –    2020-05-12 4 A $72.29 $260,244 I/I 3,600 8,527     -
   Carroll J Martin Director   –       •      –    2020-05-12 4 D $72.29 $260,244 I/I (3,600) 0     -
   Carroll J Martin Director   –       •      –    2020-05-12 4 GA $0.00 $0 I/I 3,600 3,600     -
   Carroll J Martin Director   –       •      –    2020-05-12 4 GD $0.00 $0 D/D 3,600 15,322     -
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2020-04-09 4 A $56.46 $13,720 D/D 243 16,189     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2020-04-09 4 A $56.46 $15,752 D/D 279 44,520     -
   Buzy Peter L President, Gene Therapy   •       –      –    2020-04-09 4 A $56.46 $15,018 D/D 266 45,950     -
   Schmidt Kay A SVP, Technical Operations   •       –      –    2020-04-09 4 A $56.46 $12,760 D/D 226 12,021     -
   Fasman Steven L SVP & General Counsel   •       –      –    2020-04-09 4 A $56.46 $21,794 D/D 386 63,206     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2020-04-09 4 A $56.46 $14,454 D/D 256 16,282     -
   Maselli Alessandro President & COO   •       –      –    2020-04-09 4 A $56.46 $17,785 D/D 315 13,117     -
   Joseph Wetteny SVP & Chief Financial Officer   •       –      –    2020-04-09 4 A $56.46 $19,705 D/D 349 46,776     -
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2020-04-09 4 A $56.46 $12,760 D/D 226 11,072     -
   Flynn Karen Pres. Biologics & CCO   •       –      –    2020-04-09 4 A $56.46 $20,269 D/D 359 35,645     -
   Whitlow Ricci S President, CSS   •       –      –    2020-04-09 4 A $56.46 $13,550 D/D 240 2,704     -
   Arnold Jonathan Pres. Oral & Specialty Deliv.   •       –      –    2020-04-09 4 A $56.46 $14,905 D/D 264 34,509     -
   Lucier Gregory T Director   –       •      –    2020-02-13 4 B $59.71 $119,420 D/D 2,000 40,921 2.39 19%     
   Schmidt Kay A SVP, Technical Operations   •       –      –    2020-02-02 4 D $61.10 $12,648 D/D (207) 11,795     -
  821 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us